Marshall Wace North America’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-5,498
| Closed | -$225K | – | 1332 |
|
|
2021
Q2 | $225K | Sell |
5,498
-26,698
| -83% | -$1.09M | ﹤0.01% | 1271 |
|
|
2021
Q1 | $1.3M | Sell |
32,196
-207,987
| -87% | -$8.37M | 0.01% | 932 |
|
|
2020
Q4 | $14.2M | Buy |
240,183
+77,139
| +47% | +$4.56M | 0.06% | 310 |
|
|
2020
Q3 | $7.93M | Buy |
+163,044
| New | +$7.93M | 0.05% | 317 |
|
|
2020
Q2 | – | Sell |
-97,230
| Closed | -$2.7M | – | 1127 |
|
|
2020
Q1 | $2.7M | Buy |
97,230
+95,711
| +6,301% | +$2.66M | 0.02% | 428 |
|
|
2019
Q4 | $46K | Sell |
1,519
-61,311
| -98% | -$1.86M | ﹤0.01% | 1159 |
|
|
2019
Q3 | $1.94M | Sell |
62,830
-136,670
| -69% | -$4.22M | 0.01% | 551 |
|
|
2019
Q2 | $9.64M | Buy |
+199,500
| New | +$9.64M | 0.06% | 246 |
|